I should probably validate before speaking but isn’t his contract and incentives driven by/include the successful transition of adderall from Lannett to ourselves? So May not be a surprise but if Lannett is by chance wanting to step back from their go it alone plans it certainly is making a high demand of focus/time on contract renegotiations with both Lannett and our in-house Market Developing friend right now. Which can’t be good as that would mean there’s not much time being allocated to the forward looking growth needed…. Hope this all gets laid out/communicated to us with answers and an action plan to execute on, not as a work in progress on getting the plan put together
News 
Market Data 
Discover 
